[Comment] The case for routine patient review in long COVID research
Summary
Long COVID is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and can lead to sometimes severe disability.1–3 In early 2024, long COVID had already affected 400 million people, with an estimated annual global economic impact of US$1 trillion.2 6 years into the COVID-19 pandemic, research into long COVID has progressed considerably, and evidence implicates several pathomechanisms, inc…
Long COVID is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and can lead to sometimes severe disability.1–3 In early 2024, long COVID had already affected 400 million people, with an estimated annual global economic impact of US$1 trillion.2 6 years into the COVID-19 pandemic, research into long COVID has progressed considerably, and evidence implicates several pathomechanisms, including aberrant immunity, persistent pathogens, endothelial dysfunction, and mitochondrial dysfunction.